ICG and Goldman back Synerlab €160m refi

The unitranche package opens a capex line and acquisition line for the pharmaceutical company, which is expected to complete two purchases in the next couple of months.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this